N/A
N=53
Utilizing Telemedicine for Delivery of Postoperative Care
Laparoscopic Gynecologic Surgery
Bottom Line
View on ClinicalTrials.gov: NCT04348357 ↗Enrolled (actual)
53
Serious AEs
0.0%
Results posted
Jul 2020
Primary outcome: Primary: PSQ-18 General Satisfaction — 4.0; 4.5 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Telemedicine (Other); Office visit (Other)
- Age
- Adult · 18+ yrs
- Sex
- Female
- Sponsor
- Texas Tech University Health Sciences Center, El Paso
- Primary completion
- May 2020
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY PSQ-18 General Satisfaction |
4.0; 4.5 | — |
| PRIMARY PSQ-18 Technical Quality |
4.0; 4.5 | — |
| PRIMARY PSQ-18 Interpersonal Manner |
4.0; 4.5 | — |
| PRIMARY PSQ-18 Communication |
4.5; 4.5 | — |
| PRIMARY PSQ-18 Time Spent With Doctor |
4.0; 4.5 | — |
| PRIMARY PSQ-18 Accessibility and Convenience |
4.0; 4.0 | — |
| SECONDARY Actual Visit Time |
9.2; 9.1 | — |
| SECONDARY Visits to Emergency Department |
1; 0 | — |
| SECONDARY Phone-calls to Office |
6; 5 | — |
| SECONDARY Time Dedicated by Patient to Complete Visit |
60.8; 14.7 | — |
| SECONDARY Number of Patients Who Desired to Switch Groups |
2; 0 | — |
Summary
The investigators propose a pilot project in which enrolled patients undergoing major gynecologic surgery will be randomized to either a traditional office postoperative visit or a telemedicine postoperative visit. The two groups will then be compared on a variety of metrics including clinical outcomes, patient satisfaction and time.
Eligibility Criteria
Inclusion criteria
- Female patients between ages 18-60
- Have access to smart-phone with video/audio and internet capabilities
- Undergoing laparoscopic gynecologic surgery that requires a postoperative visit
- Total laparoscopic hysterectomy
- Laparoscopic removal of adnexal structures
- Laparoscopic excision of endometriosis
Exclusion criteria
- Patient unwilling to participate
- The patient is unwilling to install and utilize the telemedicine app on their smartphone.
Data sourced from ClinicalTrials.gov (NCT04348357). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.